Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL
更正:1B7/CD3 是一种新型抗 TSLPR 双特异性抗体,靶向 CRLF2 重排的 Ph 样 B 细胞急性淋巴细胞白血病 (B-ALL),目前正处于临床前开发阶段。
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-023-02090-w
Tian, Ze; Shi, Chunhua; Yang, Guojun; Allen, Jason K; Shi, Qing; Al-Shami, Amin; Olson, Jill Wardell; Smith, Melinda G; Chang, Qing; Kaur, Jasbir; You, Junping; Lofton, Timothy E; Gonzalez, Michelle A; Zhang, Qi; Zha, DongXing; Tasian, Sarah K; Jain, Nitin; Konopleva, Marina Y; Heffernan, Timothy; Molldrem, Jeffrey J